Elisabeth Rippy

647 citations
5 papers · 73 indexed · h-index 4
Topics
Effects and risks of endocrine disrupting chemicals (1 paper)Estrogen and related hormone effects (1 paper)Cancer Risks and Factors (1 paper)

In The Last Decade

Elisabeth Rippy

4 papers receiving 69 citations

Peers

Elisabeth Rippy
Comparison fields: 5 of 27
  • Oncology 51
  • Public Health, Environmental and Occupational Health 27
  • Cancer Research 18
  • Genetics 16
  • Pathology and Forensic Medicine 15
Replace Theo A. van Os with:
Theo A. van Os Netherlands
Leslie E. Oldfield Canada
Inge M. Krul Netherlands
Ted Trimble United States
Rachel Kessel United States
Marieke G. M. Braem Netherlands
Ilana Cass United States
D. Zarca France
Rachel Hodan United States
Cassandra Nichols Australia
Elisabeth Rippy relative to Theo A. van Os Netherlands Theo A. van Os's profile →
Citations per field
00.5×1.5×2.5×
Theo A. van Os · 1×
Citations per year

Countries citing papers authored by Elisabeth Rippy

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Rippy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Rippy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Rippy more than expected).

Fields of papers citing papers by Elisabeth Rippy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Rippy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Rippy. The network helps show where Elisabeth Rippy may publish in the future.

Co-authorship network of co-authors of Elisabeth Rippy

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Rippy. A scholar is included among the top collaborators of Elisabeth Rippy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Rippy. Elisabeth Rippy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Elisabeth Rippy

Elisabeth Rippy is a scholar working on Dermatology, Pathology and Forensic Medicine and Health, Toxicology and Mutagenesis, having authored 5 papers that have together received 73 indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (1 paper), Estrogen and related hormone effects (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Oncology (51 citations), Reproductive Medicine (12 citations) and Cancer Research (18 citations). Elisabeth Rippy has collaborated with scholars based in Australia, Switzerland and United Kingdom. Frequent co-authors include M W Kissin, James Kollias, Melissa Bochner, Robert J. Whitfield, Dharshan Sathananthan, Rachel Ainsworth, J.H.N. Wolfe, Shalini Jindal, David F. Callen and Howard A. Morris. Their work appears in journals such as Molecular and Cellular Endocrinology, The Breast and Vascular and Endovascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026